Keystone eSymposia Logo

Innovative Vaccine Approaches

June 28-30, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change


Reset

Advanced Filters
Welcoming Remarks and Keynote Address
09:00am - 09:40am Eastern - June 28, 2021
Mariagrazia Pizza, PhD, Co-Chair, GlaxoSmithKline Vaccines; Galit Alter, PhD, Co-Chair, MIT and Harvard University
Track: Welcoming Remarks and Keynote Address

Monday
Vaccines 2030
09:00am - 09:40am Eastern - June 28, 2021
Rino Rappuoli, PhD, GlaxoSmithKline Vaccines
Track: Welcoming Remarks and Keynote Address

Shifting the Paradigm in Global Health and AMR
09:40am - 12:40pm Eastern - June 28, 2021
Galit Alter, PhD, Co-Chair, MIT and Harvard University; Keith Klugman, Co-Chair, Bill and Melinda Gates Foundation
Track: Shifting the Paradigm in Global Health and AMR

Monday
The Role of Vaccines in Combatting Antimicrobial Resistance (AMR)
09:40am - 10:05am Eastern - June 28, 2021
Elizabeth Klemm, PhD, Wellcome Trust
Track: Shifting the Paradigm in Global Health and AMR

Monday
Oral Vaccine Induced Immunity in Lower Income Settings
10:05am - 10:30am Eastern - June 28, 2021
Gagandeep Kang, MD, PhD, Christian Medical College/Translational Health Science and Technology Institute
Track: Shifting the Paradigm in Global Health and AMR

Monday
Challenges in the Field
10:30am - 10:55am Eastern - June 28, 2021
Ankur Mutreja, PhD, University of Cambridge
Track: Shifting the Paradigm in Global Health and AMR

Monday
An Invariant Trypanosoma Vivax Vaccine Antigen Induces Protective Immunity
11:20am - 11:45am Eastern - June 28, 2021
Gavin J. Wright, PhD, Wellcome Trust Sanger Institute
Track: Shifting the Paradigm in Global Health and AMR

Monday
GMMA as Antigen and Delivery System
11:45am - 12:10pm Eastern - June 28, 2021
Mariagrazia Pizza, PhD, GlaxoSmithKline Vaccines
Track: Shifting the Paradigm in Global Health and AMR

Monday
Short Talk: Vaccine Driven Lung TRM Cells Provide Immunity Against Klebsiella via Fibroblast IL-17R Signaling
12:25pm - 12:40pm Eastern - June 28, 2021
Joseph Paul Hoffmann, PhD, Tulane University School of Medicine
Track: Shifting the Paradigm in Global Health and AMR

Monday
Meet the Editors Roundtable
02:30pm - 03:30pm Eastern - June 28, 2021
Alexandra Flemming, Nature Publishing Group; Paula Jauregui Onieva, PLOS (Public Library of Science); Ines Pires, Frontiers In Tropical Diseases; Gaia Trincucci, PhD, Journal of Experimental Medicine
Track: Keystone Symposia Roundtables

COVID and Pan COVID Vaccines: Technologies and Criticalities
09:00am - 12:25pm Eastern - June 29, 2021
Lynda M. Stuart, MD, PhD, Co-Chair, Bill & Melinda Gates Foundation; Gordon Dougan, PhD, Co-Chair, University of Cambridge
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
New Humoral OMIC Tools to Mine for Correlates of Immunity
09:00am - 09:25am Eastern - June 29, 2021
Galit Alter, PhD, MIT and Harvard University
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
mRNA Based Vaccines
09:25am - 09:50am Eastern - June 29, 2021
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
Viral Vectors
09:50am - 10:15am Eastern - June 29, 2021
Andrew J. Pollard, MD, PhD, University of Oxford
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
From Diversity to Protection
10:15am - 10:40am Eastern - June 29, 2021
Florian Krammer, PhD, Icahn School of Medicine at Mount Sinai
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
SARS-COV2 Spread and Evolution to Instruct Pan- Vaccine Development Strategies
10:40am - 11:05am Eastern - June 29, 2021
Ravi K. Gupta, MD, University of Cambridge
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
Epidemiological and Evolutionary Considerations of SARS-CoV-2 Vaccine Administration Schemes
11:30am - 11:55am Eastern - June 29, 2021
Caroline E. Wagner, PhD, McGill University
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
Short Talk: INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T Cell Activity Against Global SARS-CoV-2 Variants
11:55am - 12:10pm Eastern - June 29, 2021
Viviane Machado, PhD, Inovio Pharmaceuticals Inc.
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Tuesday
Short Talk: Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
12:10pm - 12:25pm Eastern - June 29, 2021
Kayvon Modjarrad, MD, PhD, Walter Reed Army Institute of Research
Track: COVID and Pan COVID Vaccines: Technologies and Criticalities

Pandemic Preparedness: Lessons from COVID
12:25pm - 01:40pm Eastern - June 29, 2021
Shabir Madhi, MD, PhD, Co-Chair, South African Medical Research Council; Christopher L. Karp, MD, Co-Chair, Bill & Melinda Gates Foundation
Track: Pandemic Preparedness: Lessons from COVID

Tuesday
Planning for Correlates for Phase 3 Studies: Lessons from COVID
12:25pm - 12:40pm Eastern - June 29, 2021
Lawrence Corey, MD, Fred Hutchinson Cancer Research Center; Peter Gilbert, PhD, Fred Hutchinson Cancer Research Center
Track: Pandemic Preparedness: Lessons from COVID

Tuesday
Changing Regulatory and Vaccine Landscape in the Face of COVID
12:40pm - 12:55pm Eastern - June 29, 2021
Gordon Dougan, PhD, University of Cambridge
Track: Pandemic Preparedness: Lessons from COVID

Tuesday
Strategies to Manufacturing, Distribution and Roll-out
12:55pm - 01:10pm Eastern - June 29, 2021
Nicole Lurie, MD, Coalition for Epidemic Preparedness Innovations - CEPI
Track: Pandemic Preparedness: Lessons from COVID

Tuesday
Panel Discussion
01:10pm - 01:40pm Eastern - June 29, 2021
Track: Pandemic Preparedness: Lessons from COVID

Tuesday
Career Roundtables
03:30pm - 04:30pm Eastern - June 29, 2021
Sanjay Ram, MD, University of Massachusetts; Amy E. Gilbert, PhD, Adaptive Biotechnologies; Elizabeth Klemm, PhD, Wellcome Trust
Track: Keystone Symposia Roundtables

Immune Correlates: 'In vivo' and 'in vitro' Model Systems
09:00am - 01:00pm Eastern - June 30, 2021
Gordon Dougan, PhD, Co-Chair, University of Cambridge; Mariagrazia Pizza, PhD, Co-Chair, GlaxoSmithKline Vaccines
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Towards a Pan-Sarbecovirus Vaccine
09:00am - 09:25am Eastern - June 30, 2021
Pamela J. Bjorkman, PhD, California Institute of Technology
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
SARS-Cov2 Human Challenge
09:25am - 09:50am Eastern - June 30, 2021
Christopher Chiu, MD, PhD, Imperial College London
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Immune Correlates of Protection from Tuberculosis
09:50am - 10:15am Eastern - June 30, 2021
Elisa Nemes, PhD, University of Cape Town
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Pneumococcal Human Infection Study in Malawi to Understand Vaccine Efficacy
10:15am - 10:40am Eastern - June 30, 2021
Stephen Gordon, MD, PhD, Liverpool School of Tropical Medicine
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Human Infection Model of Group A Streptococcus Pharyngitis
10:40am - 11:05am Eastern - June 30, 2021
Andrew Steer, MD, Murdoch Children's Research Institute
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Innovative 3D Infection Models as Validation Tools for Vaccine Research
11:30am - 11:55am Eastern - June 30, 2021
Thomas Rudel, PhD, University of Würzburg
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Single Cell Omics from SARS-COV2 Spread and Evolution to Instruct Pan-Vaccine Development Strategies
11:55am - 12:20pm Eastern - June 30, 2021
Catherine A. Blish, MD, PhD, Stanford University School of Medicine
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday

Wednesday
Short Talk: Cytosolic dsRNA Improves Neonatal Innate Immune Responses to Adjuvants Currently in Use in Paediatric Vaccines
12:35pm - 12:50pm Eastern - June 30, 2021
Kiva V. Brennan, PhD, Trinity College Dublin
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems

Wednesday
Closing Remarks
12:50pm - 01:00pm Eastern - June 30, 2021
Gordon Dougan, PhD, University of Cambridge
Track: Immune Correlates: 'In vivo' and 'in vitro' Model Systems